limited data exist on the safety of the measles, mumps, and rubella (mmr) vaccine in adults. we identified 131 reports of mmr vaccine administered to a pregnant woman; the majority of these vaccinations were in the first trimester and in 83 (62%), no ae was reported. to evaluate the safety of mmr in adults and inform potential catch-up vaccination programs, we reviewed reports to the vaccine adverse event reporting system (vaers) following mmr for individuals aged ≥19 years. for anaphylaxis, we included reports if symptoms began the day of vaccination or the day following vaccination (days 0–1). mmr reports were compared to all other vaccines in the vaers database . in 4 reports, the listed cause of death was cardiac or cardiovascular in origin. one patient who received concomitant dryvax smallpox vaccine had a history of myocarditis after receiving the same vaccine 6 years earlier.
of the 2 nonserious reports, 1 met brighton level 2 case definition of itp and the other had insufficient information for evaluation. in a patient with symptom onset the day following vaccination with mmr, hepatitis b, and tetanus-diphtheria vaccines, a neurologist determined the event was not related to vaccination. of the pregnancy ae reports, 44 (32.8%) were in patients receiving mmr vaccine alone. we conducted a comprehensive review of vaers reports following mmr in adults aged ≥19 years, including automated analysis of reports; clinical review of serious reports, pregnancy reports, and reports of prespecified outcomes; and data mining to assess for disproportionate reporting. additionally, we are unable to determine the number of doses of mmr administered to adults during the study period because mmr vaccination coverage in adults is not available through national surveys. we identified reports of pregnant women vaccinated with mmr, a group in whom the vaccine is contraindicated, which demonstrates the need for continued provider education on vaccine recommendations and screening for contraindications. characteristics of 131 pregnancy reports to the vaccine adverse event reporting system following measles, mumps, and rubella vaccine in adults aged ≥19 years, 1 january 2003–31 july 2013 adverse events in pregnant women reported to the vaccine adverse event reporting system following measles, mumps, and rubella vaccine (n = 134a), 1 january 2003–31 july 2013
information provided to vaers which identifies a person who received the vaccine or vaccines will not be made available to the public. de-identified vaers data as contraindications to additional doses of vaccine. (interval – see package insert). measles, mumps and rubella in any combination;. mmr, mmrv, mm. report an adverse event using the vaers online form or the downloadable pdf. new! important: if you are experiencing a medical emergency, seek immediate, vaers database, vaers database, vaers data myocarditis, vaers id 1074247, adverse events database.
vaers is the national vaccine safety monitoring system that accepts reports of adverse events after vaccination. the system can quickly detect potential we retrieved data from the vaers database, a national postlicensure vaccine safety surveillance system, through the cdc wonder interface for we retrieved data from the vaccine adverse event reporting system (vaers) database, a national post-licensure vaccine safety surveillance system,, from the 1/29/2021 release of vaers data, vaers myocarditis 2021, vaers lymphoma, vaers id 1261766, report moderna vaccine side effects, vaers covid vaccine tinnitus, vaers data use guide, cdc covid vaccine side effects, vaers 1166062, vaers i.d. 1225942 1.
When you try to get related information on vaers mmr, you may look for related areas. vaers database, vaers data myocarditis, vaers id 1074247, adverse events database, from the 1/29/2021 release of vaers data, vaers myocarditis 2021, vaers lymphoma, vaers id 1261766, report moderna vaccine side effects, vaers covid vaccine tinnitus, vaers data use guide, cdc covid vaccine side effects, vaers 1166062, vaers i.d. 1225942 1.